Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Firmly Holding Gold and Steadily Expanding Gold Business, Blue Hat (BHAT) Reports on Gold Holdings Performance
-
Quantum Solutions aims for top 5 BTC treasury backed by Forbes owner
-
$LYNO Presale in 3 Days: The Decentralized AI Arbitrage Protocol Changing Cross-Chain Trading Forever
-
MACOM Completes Transfer of RTP Wafer Fab
-
Apex Group and ZIGChain Forge Strategic Alliance to Launch Tokenized Fund Infrastructure
-
Neinor Homes accelerates growth in 1H25 with 1,701# pre-sold (+45%), while reaffirms its FY25 targets
-
Ponce Financial Group, Inc. Reports Second Quarter 2025 Results
-
UPCX Wallet Releases New Features and Opens Testnet for Public Testing
-
TX OFFER: Cash for Houses Company Unveils ‘Sell Your House Fast In Houston, TX’ Service
-
ZimVie to Report Second Quarter 2025 Financial Results on July 30, 2025
-
Fusion Fuel Announces New LPG Projects for Subsidiary Al Shola Gas
-
On.bet Launches New Online Gambling Platform Tailored for the Indian Market
-
Beyond Air Schedules First Fiscal Quarter 2026 Financial Results Conference Call and Webcast
-
LGI Homes Debuts Robindale Community East of Downtown Winston-Salem
-
Netflix and K Wave Media Launch Global Action Thriller Series "Trigger" on July 25
-
Madrigal Pharmaceuticals to Release Second-Quarter 2025 Financial Results and Host Webcast on August 5, 2025
-
Winshear Receives TSXV Approval to the Thunder Bay Gold Project, NW Ontario and Grants Director Stock Options
-
Transom Capital and SigmaTron International Announce Expiration of Tender Offer
-
GivBux Urges Shareholders to Submit Statements as Share Reconciliation Continues
-
Nano Labs Donates to Establish the “Nano bit Blockchain Research Fund” at Peking University’s Guanghua School of Management, Supporting Innovation in Blockchain Research
-
Conor McGregor, MMA.INC Investor, Welcomes Laura Sanko to Company’s Board
-
First Hawaiian, Inc. Reports Second Quarter 2025 Financial Results and Declares Dividend
-
Lyell Immunopharma Announces up to $100 Million Equity Private Placement
-
PureCycle Schedules Second Quarter 2025 Corporate Update
-
SharpLink Welcomes BlackRock Digital Assets Pioneer Joseph Chalom as Newly Appointed Co-CEO
-
CareCloud Announces Preferred Stock Dividend Payments
-
Netflix and K Wave Media Launch Global Action Thriller Series "Trigger" on July 25
-
Cronos Group Inc. to Hold 2025 Second Quarter Earnings Conference Call on August 7, 2025
-
Gentex Reports Second Quarter 2025 Financial Results
-
Orangekloud Announces Launch of eMOBIQ® AI Platform
-
Kenyan Cabinet Secretary supports Private Sector Civic-Led National Digital Token as Symbol of Identity and Innovation
-
Buxton Helmsley Releases Open Letter to Daily Journal Corporation Shareholders
-
Postal Realty Trust, Inc. to Report Second Quarter 2025 Financial Results on August 4, 2025
-
Pampa Metals and Rugby Resources Complete Arrangement Transaction
-
BriaCell Announces Two Clinical Data Poster Presentations at ESMO 2025
-
Saia Reports Second Quarter Results
-
Bombardier Delivers the First Challenger 3500 Business Jet in Costa Rica
-
Incannex Healthcare Expands Clinical Advisory Board to Support Obstructive Sleep Apnea Program with Appointment of Dr. Charlene E. Gamaldo
-
Colliers completes acquisition of Astris Finance
-
Form 8.3 - [MARLOWE PLC - 24 07 2025] - (CGWL)
-
ZURZUVAE® (zuranolone) Receives Positive Opinion from CHMP for the Treatment of Women with Postpartum Depression
-
Gencor Releases Second Quarter Fiscal 2025 Results
-
Gencor Releases First Quarter Fiscal 2025 Results
-
Lakeland Financial Reports Record Second Quarter Performance; Net Income Grows by 20% to $27.0 Million, as Net Interest Income Expands by 14%
-
OMS Energy Technologies Inc. Filed 2025 Annual Report on Form 20-F
-
Sobi Announces U.S. Food and Drug Administration Approves Doptelet® (avatrombopag) for the Treatment of Thrombocytopenia in Pediatric Patients One Year and Older with Persistent or Chronic Immune Thr
-
Enthusiast Gaming Announces Closing of Debt Financing
-
Gogo to Report Second Quarter 2025 Financial Results on August 7, 2025
-
Castle Biosciences’ Founder, President and CEO Derek Maetzold Named a Most Admired CEO by the Houston Business Journal
-
Roche provides regulatory update on Elevidys™ gene therapy for Duchenne muscular dystrophy in the EU

